This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Carter Bankshares, Inc. (CARE) Meets Q2 Earnings Estimates
by Zacks Equity Research
Carter Bankshares (CARE) delivered earnings and revenue surprises of 0% and 2.31%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Take the Zacks Approach to Beat the Markets: NVIDIA, Seagate, Amkor in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Carter Bankshares (CARE) Soars 5.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Carter Bankshares (CARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Surging Earnings Estimates Signal Upside for Carter Bankshares (CARE) Stock
by Zacks Equity Research
Carter Bankshares (CARE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
How Much Upside is Left in Carter Bankshares (CARE)? Wall Street Analysts Think 28.92%
by Zacks Equity Research
The mean of analysts' price targets for Carter Bankshares (CARE) points to a 28.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Implied Volatility Surging for Carter Bankshares (CARE) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.
Wall Street Analysts See a 30.85% Upside in Carter Bankshares (CARE): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 30.9% upside potential for Carter Bankshares (CARE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Compared to Estimates, Carter Bankshares (CARE) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cambridge (CATC) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Cambridge (CATC) delivered earnings and revenue surprises of -2.86% and 1.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Blue Foundry Bancorp (BLFY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Blue Foundry Bancorp (BLFY) delivered earnings and revenue surprises of 7.14% and 1.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carter Bankshares, Inc. (CARE) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Carter Bankshares, Inc. (CARE) Meets Q3 Earnings Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 0% and 1.59%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Equity Bancshares (EQBK) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Equity Bancshares (EQBK) delivered earnings and revenue surprises of 5.26% and 2.30%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of -61.29% and 29.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter Bankshares, Inc. (CARE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 9.68% and 2.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Bridgewater (BWB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Bridgewater (BWB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Carter Bankshares, Inc. (CARE) Earnings Expected to Grow: What to Know Ahead of Q1 Release
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Carter Bankshares, Inc. (CARE) Could Beat Earnings Estimates Again
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Carter Bankshares, Inc. (CARE) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) delivered earnings and revenue surprises of 1.64% and 6.61%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Business First (BFST) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Business First (BFST) delivered earnings and revenue surprises of 8.20% and 3.86%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Best Value Stocks to Buy for December 28th
by Zacks Equity Research
CARE, ADT and MUSA made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 28, 2022.
Is Carter Bankshares (CARE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Carter Bankshares, Inc. (CARE) Loses 9.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Carter Bankshares, Inc. (CARE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.